APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Drugs and Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pediatric Drugs and Vaccines Industry Growth and Trends Forecast to 2032

20 December 2025111 pages

Choose your research edition.

Industry ResearchPediatric Drugs and Vaccines Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Drugs and Vaccines Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pediatric Drugs and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Drugs and Vaccines Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Drugs and Vaccines Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Pediatric Drugs and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pediatric Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pediatric Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pediatric Drugs and Vaccines include Janssen Biologics B.V. (USA), Takeda, Sanofi S.A (France), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Merck & Co., Inc. (USA), Eli Lilly and Company (USA), Pfizer, Inc. (USA) and GlaxoSmithKline plc. (UK), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pediatric Drugs and Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pediatric Drugs and Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pediatric Drugs and Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pediatric Drugs and Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pediatric Drugs and Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pediatric Drugs and Vaccines Market by Company

Janssen Biologics B.V. (USA)

Takeda

Sanofi S.A (France)

Novartis AG (Switzerland)

Novo Nordisk A/S (Denmark)

Merck & Co., Inc. (USA)

Eli Lilly and Company (USA)

Pfizer, Inc. (USA)

GlaxoSmithKline plc. (UK)

Amgen, Inc. (USA)

Shionogi Inc. (USA)

Genentech, Inc. (USA)

F. Hoffmann-La Roche Ltd (Switzerland)

Bristol-Myers Squibb Company (USA)

Boehringer Ingelheim GmbH (Germany)

AstraZeneca Plc. (UK)

Allergan, Inc. (USA)

Actelion Pharmaceuticals

Abbott Laboratories (USA)

Pediatric Drugs and Vaccines Segment by Type

Diphtheria

Pneumococcal Diseases

Hepatitis

Influenza

Mumps

Meningococcal Diseases

Others

Pediatric Drugs and Vaccines Segment by Application

Child

Newborn

Infant

Pediatric Drugs and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Drugs and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Drugs and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Drugs and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pediatric Drugs and Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pediatric Drugs and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Diphtheria Table 2. Major Company of Pneumococcal Diseases Table 3. Major Company of Hepatitis Table 4. Major Company of Influenza Table 5. Major Company of Mumps Table 6. Major Company of Meningococcal Diseases Table 7. Major Company of Others Table 8. Global Pediatric Drugs and Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 10. Global Pediatric Drugs and Vaccines Sales Market Share in Volume by Type (2021-2026) Table 11. Global Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 12. Global Pediatric Drugs and Vaccines Sales Market Share in Value by Type (2021-2026) Table 13. Global Pediatric Drugs and Vaccines Price by Type (2021-2026) & (US$/Unit) Table 14. Global Pediatric Drugs and Vaccines Sales by Type (2027-2032) & (K Units) Table 15. Global Pediatric Drugs and Vaccines Sales Market Share in Volume by Type (2027-2032) Table 16. Global Pediatric Drugs and Vaccines Sales by Type (2027-2032) & (US$ Million) Table 17. Global Pediatric Drugs and Vaccines Sales Market Share in Value by Type (2027-2032) Table 18. Global Pediatric Drugs and Vaccines Price by Type (2027-2032) & (US$/Unit) Table 19. North America Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 20. North America Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 22. Europe Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 26. Latin America Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (US$ Million) Table 29. Pediatric Drugs and Vaccines Industry Trends Table 30. Pediatric Drugs and Vaccines Industry Drivers Table 31. Pediatric Drugs and Vaccines Industry Opportunities and Challenges Table 32. Pediatric Drugs and Vaccines Industry Restraints Table 33. Global Pediatric Drugs and Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2021-2026) Table 35. Global Pediatric Drugs and Vaccines Sales by Company (2021-2026) & (K Units) Table 36. Global Pediatric Drugs and Vaccines Sales Share by Company (2021-2026) Table 37. Global Pediatric Drugs and Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Pediatric Drugs and Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Pediatric Drugs and Vaccines Major Company Production Sites and Headquarters Table 40. Global Pediatric Drugs and Vaccines Company, Product Type & Application Table 41. Global Pediatric Drugs and Vaccines Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Pediatric Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Pediatric Drugs and Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Pediatric Drugs and Vaccines Sales by Region (2021-2026) & (K Units) Table 46. Global Pediatric Drugs and Vaccines Sales Market Share in Volume by Region (2021-2026) Table 47. Global Pediatric Drugs and Vaccines Sales by Region (2021-2026) & (US$ Million) Table 48. Global Pediatric Drugs and Vaccines Sales Market Share in Value by Region (2021-2026) Table 49. Global Pediatric Drugs and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Pediatric Drugs and Vaccines Sales by Region (2027-2032) & (K Units) Table 51. Global Pediatric Drugs and Vaccines Sales Market Share in Volume by Region (2027-2032) Table 52. Global Pediatric Drugs and Vaccines Sales by Region (2027-2032) & (US$ Million) Table 53. Global Pediatric Drugs and Vaccines Sales Market Share in Value by Region (2027-2032) Table 54. Global Pediatric Drugs and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Pediatric Drugs and Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 57. Global Pediatric Drugs and Vaccines Sales Market Share in Volume by Application (2021-2026) Table 58. Global Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 59. Global Pediatric Drugs and Vaccines Sales Market Share in Value by Application (2021-2026) Table 60. Global Pediatric Drugs and Vaccines Price by Application (2021-2026) & (US$/Unit) Table 61. Global Pediatric Drugs and Vaccines Sales by Application (2027-2032) & (K Units) Table 62. Global Pediatric Drugs and Vaccines Sales Market Share in Volume by Application (2027-2032) Table 63. Global Pediatric Drugs and Vaccines Sales by Application (2027-2032) & (US$ Million) Table 64. Global Pediatric Drugs and Vaccines Sales Market Share in Value by Application (2027-2032) Table 65. Global Pediatric Drugs and Vaccines Price by Application (2027-2032) & (US$/Unit) Table 66. North America Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 67. North America Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 69. Europe Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 73. Latin America Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (US$ Million) Table 76. Janssen Biologics B.V. (USA) Company Information Table 77. Janssen Biologics B.V. (USA) Business Overview Table 78. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 80. Janssen Biologics B.V. (USA) Recent Development Table 81. Takeda Company Information Table 82. Takeda Business Overview Table 83. Takeda Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Takeda Pediatric Drugs and Vaccines Product Portfolio Table 85. Takeda Recent Development Table 86. Sanofi S.A (France) Company Information Table 87. Sanofi S.A (France) Business Overview Table 88. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio Table 90. Sanofi S.A (France) Recent Development Table 91. Novartis AG (Switzerland) Company Information Table 92. Novartis AG (Switzerland) Business Overview Table 93. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio Table 95. Novartis AG (Switzerland) Recent Development Table 96. Novo Nordisk A/S (Denmark) Company Information Table 97. Novo Nordisk A/S (Denmark) Business Overview Table 98. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio Table 100. Novo Nordisk A/S (Denmark) Recent Development Table 101. Merck & Co., Inc. (USA) Company Information Table 102. Merck & Co., Inc. (USA) Business Overview Table 103. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 105. Merck & Co., Inc. (USA) Recent Development Table 106. Eli Lilly and Company (USA) Company Information Table 107. Eli Lilly and Company (USA) Business Overview Table 108. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio Table 110. Eli Lilly and Company (USA) Recent Development Table 111. Pfizer, Inc. (USA) Company Information Table 112. Pfizer, Inc. (USA) Business Overview Table 113. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 115. Pfizer, Inc. (USA) Recent Development Table 116. GlaxoSmithKline plc. (UK) Company Information Table 117. GlaxoSmithKline plc. (UK) Business Overview Table 118. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio Table 120. GlaxoSmithKline plc. (UK) Recent Development Table 121. Amgen, Inc. (USA) Company Information Table 122. Amgen, Inc. (USA) Business Overview Table 123. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 125. Amgen, Inc. (USA) Recent Development Table 126. Shionogi Inc. (USA) Company Information Table 127. Shionogi Inc. (USA) Business Overview Table 128. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 130. Shionogi Inc. (USA) Recent Development Table 131. Genentech, Inc. (USA) Company Information Table 132. Genentech, Inc. (USA) Business Overview Table 133. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 135. Genentech, Inc. (USA) Recent Development Table 136. F. Hoffmann-La Roche Ltd (Switzerland) Company Information Table 137. F. Hoffmann-La Roche Ltd (Switzerland) Business Overview Table 138. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio Table 140. F. Hoffmann-La Roche Ltd (Switzerland) Recent Development Table 141. Bristol-Myers Squibb Company (USA) Company Information Table 142. Bristol-Myers Squibb Company (USA) Business Overview Table 143. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio Table 145. Bristol-Myers Squibb Company (USA) Recent Development Table 146. Boehringer Ingelheim GmbH (Germany) Company Information Table 147. Boehringer Ingelheim GmbH (Germany) Business Overview Table 148. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio Table 150. Boehringer Ingelheim GmbH (Germany) Recent Development Table 151. AstraZeneca Plc. (UK) Company Information Table 152. AstraZeneca Plc. (UK) Business Overview Table 153. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio Table 155. AstraZeneca Plc. (UK) Recent Development Table 156. Allergan, Inc. (USA) Company Information Table 157. Allergan, Inc. (USA) Business Overview Table 158. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 160. Allergan, Inc. (USA) Recent Development Table 161. Actelion Pharmaceuticals Company Information Table 162. Actelion Pharmaceuticals Business Overview Table 163. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio Table 165. Actelion Pharmaceuticals Recent Development Table 166. Abbott Laboratories (USA) Company Information Table 167. Abbott Laboratories (USA) Business Overview Table 168. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio Table 170. Abbott Laboratories (USA) Recent Development Table 171. North America Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. North America Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 173. North America Pediatric Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 174. North America Pediatric Drugs and Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 175. North America Pediatric Drugs and Vaccines Sales Market Share Forecast by Country (2027-2032) Table 176. North America Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Pediatric Drugs and Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Pediatric Drugs and Vaccines Market Share by Country (2021-2026) Table 179. North America Pediatric Drugs and Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Pediatric Drugs and Vaccines Market Share Forecast by Country (2027-2032) Table 181. Europe Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Europe Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 183. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 184. Europe Pediatric Drugs and Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 185. Europe Pediatric Drugs and Vaccines Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Pediatric Drugs and Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Pediatric Drugs and Vaccines Market Share by Country (2021-2026) Table 189. Europe Pediatric Drugs and Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Pediatric Drugs and Vaccines Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 193. Asia-Pacific Pediatric Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Pediatric Drugs and Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 195. Asia-Pacific Pediatric Drugs and Vaccines Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Pediatric Drugs and Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Pediatric Drugs and Vaccines Market Share by Country (2021-2026) Table 199. Asia-Pacific Pediatric Drugs and Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Pediatric Drugs and Vaccines Market Share Forecast by Country (2027-2032) Table 201. Latin America Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Latin America Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 203. Latin America Pediatric Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 204. Latin America Pediatric Drugs and Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 205. Latin America Pediatric Drugs and Vaccines Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Pediatric Drugs and Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Pediatric Drugs and Vaccines Market Share by Country (2021-2026) Table 209. Latin America Pediatric Drugs and Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Pediatric Drugs and Vaccines Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 213. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Pediatric Drugs and Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 215. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Pediatric Drugs and Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Pediatric Drugs and Vaccines Market Share by Country (2021-2026) Table 219. Middle East and Africa Pediatric Drugs and Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Pediatric Drugs and Vaccines Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Pediatric Drugs and Vaccines Distributors List Table 224. Pediatric Drugs and Vaccines Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Pediatric Drugs and Vaccines Image Figure 2. Global Pediatric Drugs and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Drugs and Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Pediatric Drugs and Vaccines Sales (2021-2032) & (K Units) Figure 5. Diphtheria Image Figure 6. Global Diphtheria Sales YoY Growth (2021-2032) & (K Units) Figure 7. Pneumococcal Diseases Image Figure 8. Global Pneumococcal Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 9. Hepatitis Image Figure 10. Global Hepatitis Sales YoY Growth (2021-2032) & (K Units) Figure 11. Influenza Image Figure 12. Global Influenza Sales YoY Growth (2021-2032) & (K Units) Figure 13. Mumps Image Figure 14. Global Mumps Sales YoY Growth (2021-2032) & (K Units) Figure 15. Meningococcal Diseases Image Figure 16. Global Meningococcal Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global Pediatric Drugs and Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Pediatric Drugs and Vaccines Market Share by Type 2025 VS 2032 Figure 21. North America Pediatric Drugs and Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. North America Pediatric Drugs and Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Europe Pediatric Drugs and Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Europe Pediatric Drugs and Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Pediatric Drugs and Vaccines Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Pediatric Drugs and Vaccines Sales Market Share in Value by Type in 2025 Figure 27. Latin America Pediatric Drugs and Vaccines Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Pediatric Drugs and Vaccines Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Pediatric Drugs and Vaccines Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Child Image Figure 34. Global Child Sales YoY Growth (2021-2032) & (K Units) Figure 35. Newborn Image Figure 36. Global Newborn Sales YoY Growth (2021-2032) & (K Units) Figure 37. Infant Image Figure 38. Global Infant Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Pediatric Drugs and Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Pediatric Drugs and Vaccines Market Share by Application 2025 VS 2032 Figure 41. North America Pediatric Drugs and Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. North America Pediatric Drugs and Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Europe Pediatric Drugs and Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Europe Pediatric Drugs and Vaccines Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Pediatric Drugs and Vaccines Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Pediatric Drugs and Vaccines Sales Market Share in Value by Application in 2025 Figure 47. Latin America Pediatric Drugs and Vaccines Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Pediatric Drugs and Vaccines Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share in Value by Application in 2025 Figure 51. North America Pediatric Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Pediatric Drugs and Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Pediatric Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Pediatric Drugs and Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Pediatric Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Pediatric Drugs and Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Pediatric Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Pediatric Drugs and Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Pediatric Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Pediatric Drugs and Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Pediatric Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Pediatric Drugs and Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Pediatric Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Pediatric Drugs and Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Pediatric Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Pediatric Drugs and Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Pediatric Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Pediatric Drugs and Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Pediatric Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Pediatric Drugs and Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Pediatric Drugs and Vaccines Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Pediatric Drugs and Vaccines Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Diphtheria
  • Pneumococcal Diseases
  • Hepatitis
  • Influenza
  • Mumps
  • Meningococcal Diseases
  • Others
Applications
  • Child
  • Newborn
  • Infant
Companies covered
  • Janssen Biologics B.V. (USA)
  • Takeda
  • Sanofi S.A (France)
  • Novartis AG (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Merck & Co., Inc. (USA)
  • Eli Lilly and Company (USA)
  • Pfizer, Inc. (USA)
  • GlaxoSmithKline plc. (UK)
  • Amgen, Inc. (USA)
  • Shionogi Inc. (USA)
  • Genentech, Inc. (USA)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Bristol-Myers Squibb Company (USA)
  • Boehringer Ingelheim GmbH (Germany)
  • AstraZeneca Plc. (UK)
  • Allergan, Inc. (USA)
  • Actelion Pharmaceuticals
  • Abbott Laboratories (USA)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pediatric Drugs and Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pediatric Drugs and Vaccines Market by Type
  6. 1.3.1 Diphtheria
  7. 1.3.2 Pneumococcal Diseases
  8. 1.3.3 Hepatitis
  9. 1.3.4 Influenza
  10. 1.3.5 Mumps
  11. 1.3.6 Meningococcal Diseases
  12. 1.3.7 Others
  13. 1.4 Global Pediatric Drugs and Vaccines Market Size by Type
  14. 1.4.1 Global Pediatric Drugs and Vaccines Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Pediatric Drugs and Vaccines Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Pediatric Drugs and Vaccines Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Pediatric Drugs and Vaccines Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Pediatric Drugs and Vaccines Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Pediatric Drugs and Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pediatric Drugs and Vaccines Industry Trends
  2. 2.2 Pediatric Drugs and Vaccines Industry Drivers
  3. 2.3 Pediatric Drugs and Vaccines Industry Opportunities and Challenges
  4. 2.4 Pediatric Drugs and Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pediatric Drugs and Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Pediatric Drugs and Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Pediatric Drugs and Vaccines Price (2021-2026)
  4. 3.4 Global Pediatric Drugs and Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pediatric Drugs and Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Pediatric Drugs and Vaccines Company, Product Type & Application
  7. 3.7 Global Pediatric Drugs and Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pediatric Drugs and Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pediatric Drugs and Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pediatric Drugs and Vaccines Tier 1, Tier 2, and Tier 3
4 Pediatric Drugs and Vaccines Regional Status and Outlook
  1. 4.1 Global Pediatric Drugs and Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pediatric Drugs and Vaccines Historic Market Size by Region
  3. 4.2.1 Global Pediatric Drugs and Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pediatric Drugs and Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pediatric Drugs and Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pediatric Drugs and Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Pediatric Drugs and Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pediatric Drugs and Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pediatric Drugs and Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pediatric Drugs and Vaccines by Application
  1. 5.1 Pediatric Drugs and Vaccines Market by Application
  2. 5.1.1 Child
  3. 5.1.2 Newborn
  4. 5.1.3 Infant
  5. 5.2 Global Pediatric Drugs and Vaccines Market Size by Application
  6. 5.2.1 Global Pediatric Drugs and Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pediatric Drugs and Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pediatric Drugs and Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pediatric Drugs and Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pediatric Drugs and Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pediatric Drugs and Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Janssen Biologics B.V. (USA)
  2. 6.1.1 Janssen Biologics B.V. (USA) Company Information
  3. 6.1.2 Janssen Biologics B.V. (USA) Business Overview
  4. 6.1.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio
  6. 6.1.5 Janssen Biologics B.V. (USA) Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Pediatric Drugs and Vaccines Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 Sanofi S.A (France)
  14. 6.3.1 Sanofi S.A (France) Company Information
  15. 6.3.2 Sanofi S.A (France) Business Overview
  16. 6.3.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio
  18. 6.3.5 Sanofi S.A (France) Recent Developments
  19. 6.4 Novartis AG (Switzerland)
  20. 6.4.1 Novartis AG (Switzerland) Company Information
  21. 6.4.2 Novartis AG (Switzerland) Business Overview
  22. 6.4.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
  24. 6.4.5 Novartis AG (Switzerland) Recent Developments
  25. 6.5 Novo Nordisk A/S (Denmark)
  26. 6.5.1 Novo Nordisk A/S (Denmark) Company Information
  27. 6.5.2 Novo Nordisk A/S (Denmark) Business Overview
  28. 6.5.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio
  30. 6.5.5 Novo Nordisk A/S (Denmark) Recent Developments
  31. 6.6 Merck & Co., Inc. (USA)
  32. 6.6.1 Merck & Co., Inc. (USA) Company Information
  33. 6.6.2 Merck & Co., Inc. (USA) Business Overview
  34. 6.6.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  36. 6.6.5 Merck & Co., Inc. (USA) Recent Developments
  37. 6.7 Eli Lilly and Company (USA)
  38. 6.7.1 Eli Lilly and Company (USA) Company Information
  39. 6.7.2 Eli Lilly and Company (USA) Business Overview
  40. 6.7.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio
  42. 6.7.5 Eli Lilly and Company (USA) Recent Developments
  43. 6.8 Pfizer, Inc. (USA)
  44. 6.8.1 Pfizer, Inc. (USA) Company Information
  45. 6.8.2 Pfizer, Inc. (USA) Business Overview
  46. 6.8.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  48. 6.8.5 Pfizer, Inc. (USA) Recent Developments
  49. 6.9 GlaxoSmithKline plc. (UK)
  50. 6.9.1 GlaxoSmithKline plc. (UK) Company Information
  51. 6.9.2 GlaxoSmithKline plc. (UK) Business Overview
  52. 6.9.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
  54. 6.9.5 GlaxoSmithKline plc. (UK) Recent Developments
  55. 6.10 Amgen, Inc. (USA)
  56. 6.10.1 Amgen, Inc. (USA) Company Information
  57. 6.10.2 Amgen, Inc. (USA) Business Overview
  58. 6.10.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  60. 6.10.5 Amgen, Inc. (USA) Recent Developments
  61. 6.11 Shionogi Inc. (USA)
  62. 6.11.1 Shionogi Inc. (USA) Company Information
  63. 6.11.2 Shionogi Inc. (USA) Business Overview
  64. 6.11.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  66. 6.11.5 Shionogi Inc. (USA) Recent Developments
  67. 6.12 Genentech, Inc. (USA)
  68. 6.12.1 Genentech, Inc. (USA) Company Information
  69. 6.12.2 Genentech, Inc. (USA) Business Overview
  70. 6.12.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  72. 6.12.5 Genentech, Inc. (USA) Recent Developments
  73. 6.13 F. Hoffmann-La Roche Ltd (Switzerland)
  74. 6.13.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Information
  75. 6.13.2 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
  76. 6.13.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
  78. 6.13.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments
  79. 6.14 Bristol-Myers Squibb Company (USA)
  80. 6.14.1 Bristol-Myers Squibb Company (USA) Company Information
  81. 6.14.2 Bristol-Myers Squibb Company (USA) Business Overview
  82. 6.14.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio
  84. 6.14.5 Bristol-Myers Squibb Company (USA) Recent Developments
  85. 6.15 Boehringer Ingelheim GmbH (Germany)
  86. 6.15.1 Boehringer Ingelheim GmbH (Germany) Company Information
  87. 6.15.2 Boehringer Ingelheim GmbH (Germany) Business Overview
  88. 6.15.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio
  90. 6.15.5 Boehringer Ingelheim GmbH (Germany) Recent Developments
  91. 6.16 AstraZeneca Plc. (UK)
  92. 6.16.1 AstraZeneca Plc. (UK) Company Information
  93. 6.16.2 AstraZeneca Plc. (UK) Business Overview
  94. 6.16.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
  96. 6.16.5 AstraZeneca Plc. (UK) Recent Developments
  97. 6.17 Allergan, Inc. (USA)
  98. 6.17.1 Allergan, Inc. (USA) Company Information
  99. 6.17.2 Allergan, Inc. (USA) Business Overview
  100. 6.17.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  102. 6.17.5 Allergan, Inc. (USA) Recent Developments
  103. 6.18 Actelion Pharmaceuticals
  104. 6.18.1 Actelion Pharmaceuticals Company Information
  105. 6.18.2 Actelion Pharmaceuticals Business Overview
  106. 6.18.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio
  108. 6.18.5 Actelion Pharmaceuticals Recent Developments
  109. 6.19 Abbott Laboratories (USA)
  110. 6.19.1 Abbott Laboratories (USA) Company Information
  111. 6.19.2 Abbott Laboratories (USA) Business Overview
  112. 6.19.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio
  114. 6.19.5 Abbott Laboratories (USA) Recent Developments
7 North America by Country
  1. 7.1 North America Pediatric Drugs and Vaccines Sales by Country
  2. 7.1.1 North America Pediatric Drugs and Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pediatric Drugs and Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Pediatric Drugs and Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pediatric Drugs and Vaccines Market Size by Country
  6. 7.2.1 North America Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pediatric Drugs and Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Pediatric Drugs and Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pediatric Drugs and Vaccines Sales by Country
  2. 8.1.1 Europe Pediatric Drugs and Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pediatric Drugs and Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Pediatric Drugs and Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pediatric Drugs and Vaccines Market Size by Country
  6. 8.2.1 Europe Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pediatric Drugs and Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pediatric Drugs and Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pediatric Drugs and Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Pediatric Drugs and Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pediatric Drugs and Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pediatric Drugs and Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pediatric Drugs and Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pediatric Drugs and Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pediatric Drugs and Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pediatric Drugs and Vaccines Sales by Country
  2. 10.1.1 South America Pediatric Drugs and Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pediatric Drugs and Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Pediatric Drugs and Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pediatric Drugs and Vaccines Market Size by Country
  6. 10.2.1 South America Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pediatric Drugs and Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Pediatric Drugs and Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Pediatric Drugs and Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pediatric Drugs and Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pediatric Drugs and Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pediatric Drugs and Vaccines Value Chain Analysis
  2. 12.1.1 Pediatric Drugs and Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pediatric Drugs and Vaccines Production Mode & Process
  7. 12.2 Pediatric Drugs and Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pediatric Drugs and Vaccines Distributors
  10. 12.2.3 Pediatric Drugs and Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst